Compare Dicks Sporting Goods Inc (DKS) vs Revvity Inc (RVTY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Dicks Sporting Goods Inc vs Revvity Inc — how do they compare? Dicks Sporting Goods Inc trades at $136.65 (market cap $13.26B), while Revvity Inc trades at $154.18 (market cap $16.98B). The key difference: Revvity Inc is the larger of the two by market cap, and Dicks Sporting Goods Inc pays the higher dividend (3.71%). Which is the better fit depends on your goals — on Pluang, investors hold Dicks Sporting Goods Inc for 19 Days and Revvity Inc for 12 Days on average.
| DKS | RVTY | |
|---|---|---|
Market Cap | $13.26B | $16.98B |
Volume | 2,292,035 | 1,456,900 |
Sector | Consumer Cyclical | Health |
52-Week High | $239.17 | $157.36 |
52-Week Low | $121.15 | $82.26 |
Typical Hold Time | 19 Days | 12 Days |
Enterprise Value | $20.31B | $19.30B |
Dividend Yield | 3.71% | 0.18% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DICK'S Sporting Goods (DKS) trades at $134.63, up 2.63% today, with a bearish technical signal from moving averages but neutral oscillators. The company shows solid profitability with a 32.05% gross margin and 18.47% ROE, though Q2 2026 earnings missed expectations. Analyst consensus is bullish with a $153.30 price target, but multiple class action lawsuits filed in October 2026 create significant headline risk.
The stock presents a mixed outlook: strong fundamentals and analyst support suggest upside potential, but legal overhangs and a recent earnings miss pose near-term risks. Investors must weigh the attractive valuation against litigation uncertainties and competitive pressures in the retail sector.
RVTY trades at $152.16, down 0.94% on the day, but maintains a bullish technical trend with strong moving average signals and support near $149. The company has consistently beaten earnings estimates in recent quarters, with Q3 2026 results expected soon. Revenue remains stable around $2.9 billion, though net income margins have softened slightly. Recent news highlights product launches and strategic acquisitions, such as the Human Cell Design deal, to bolster its life sciences portfolio.
The outlook is supported by analyst optimism with a 51.72% buy rating and a consensus price target of $132.13, though the current price trades above this target. Key risks include premium valuation metrics, margin pressures, and exposure to macroeconomic headwinds. The stock's proximity to its 52-week high suggests momentum but warrants caution given rich multiples.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Dicks Sporting Goods Inc
Dick's Sporting Goods is a leading omni-channel sporting goods retailer in the US It offers an extensive assortment of authentic sports equipment, apparel, footwear, and accessories through its stores and digital platforms.
Read more on DKS →About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →
